RecruitingPhase 4NCT05521789

Erector Spinae Block for Thoracic Surgery

Erector Spinae Blocks for Thoracic Surgery


Sponsor

George Washington University

Enrollment

70 participants

Start Date

Jul 22, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of this study is to determine if erector spinae injections with bolus infusions with local anesthetic decrease postsurgical pain and opioid consumption in patients undergoing pulmonary resection surgery.


Eligibility

Min Age: 18 YearsMax Age: 90 Years

Inclusion Criteria2

  • pulmonary resection
  • \<age\<90

Exclusion Criteria6

  • pleurodesis
  • decortication
  • emergent surgery
  • local anesthetic allergy
  • intraoperative complication (inadvertent hemorrhage or conversion to open surgery)
  • bilateral pulmonary resection

Interventions

DRUGESB Thoracic

Erector spinae thoracic block with bupivacaine


Locations(1)

The George Washington University

Washington D.C., District of Columbia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05521789


Related Trials